Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Chiesi releases additional batches of Clenil Modulite 100mcg

Chiesi has released additional Clenil Modulite 100mcg (beclometasone) batches into the UK supply chain following a steep rise in the demand for the product.

The batches have been released following the Medicines and Healthcare products Regulatory Agency’s (MHRA) authorisation.


The batch numbers authorised by MHRA for release include: 1112190, 1112214, 1112215, 1112217, 1112218, and 1112219.

The first seven batches are expected to be in circulation this week. Further batches will be released over the coming months to address the increase in demand.

“We repeat our appeal to all healthcare professionals involved in prescribing and dispensing our range of products to help us maintain supply by continuing to write monthly repeat prescriptions rather than prescriptions for multiple months’ supply of inhalers until such time as the short-term pressures begin to ease," Chiesi said in a statement.

"This will help us immensely in being able to continue to supply all our products to all our patients during this time by bringing demand in line with supply.”

Key points related to the batch variation

  • These inhalers contain the same active ingredient, beclometasone; no changes are needed to the prescription or the way patients manage their asthma
  • Drug is delivered by the same inhaler device-pressurised metered dose inhaler, pMDI
  • The main changes relate to the product appearance: on the new batches the actuator is beige and the cap is yellow, instead of brown and beige, respectively on the original version
  • There is no dose indicator on the new batches
  • There are no differences to the safety profile (adverse effects) of the drug
  • When dispensing the product, healthcare professionals should carefully check the dosage written on the labelling on the package due to the similarities in colour with Clenil 50mcg inhaler
  • As usual, patients should be recommended to keep track of when they started using the inhaler as there is no dose indicator; at the usual recommended dose the inhaler will last over a month
  • The Clenil inhalers are compatible with a Volumatic Spacer Device
  • Patients should be reminded of the importance of cleaning their inhaler once a week.

More For You

Arthritis is the leading cause of disability amongst adults

Arthritis is the leading cause of disability amongst adults

Pic credit: iStock

Supporting patient with arthritis

Community pharmacies can not only offer healthy living advice but also stock medication and supplements that give people relief from chronic pain.

Community pharmacists can be a source of knowledge to help individuals that may be suffering from joint complaints, this may be from the specific conditions such osteoarthritis, rheumatoid arthritis, gout or just general aches and pains that come from daily activities.

Keep ReadingShow less
Professional headshot of Henry Gregg, new Chief Executive of the National Pharmacy Association.

Henry Gregg

Henry Gregg begins role as NPA chief executive

New National Pharmacy Association (NPA) chief executive, Henry Gregg, officially started in his new role on Tuesday (27).

Gregg replaces Paul Rees who left the NPA at the beginning of the year to take up a similar role at the Nursing and Midwifery Council.

Keep ReadingShow less
Men in England die nearly four years earlier than women

Men in England die nearly four years earlier than women

Pic credit: iStock

Pharmacies can drive men’s health strategy

With an estimated 65 per cent of men saying they avoid seeking medical attention for as long as possible, community pharmacies can help remove barriers to accessing healthcare.

The government is currently urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

Keep ReadingShow less
Pharmacy Business Awards trophy with a celebratory background, symbolizing achievement and recognition.

Left to Right: Shailesh Solanki, Stephen Kinnock MP, Wole and Bola Ososami (winners of Pharmacy Business of the Year 2024), Barry Gardiner MP, Kalpesh Solanki and Rory Bremner

Pharmacists are urged to celebrate their success

The Pharmacy Business Awards are one of the most prestigious events in the pharmacy calendar, recognising the achievements of professionals within the sector and the outstanding contribution they make to public health. Head judge Shilpa Shah looks at why you should submit your entry for this year’s awards…

Have you sent in your nomination(s) in yet for the Pharmacy Business Awards 2025? What are you waiting for? For many years community pharmacy has been overlooked as a sector. We now have a new government that have said how much they value community pharmacy. Events such as the Pharmacy Business Awards allow us to showcase the best of the best.

Keep ReadingShow less
Medicines waste: Pharmacists explain root causes and remedies

According to the Department of Health, unused medicines cost the NHS approximately £300 million ev

Pic credit: iStock

Medicines waste: Pharmacists explain root causes and remedies

Atul Patel and Pritee Panchmatia are calling for urgent reforms—including mandatory 28-day prescriptions and a two-pharmacist model to reduce unnecessary medicines waste.

Pharmacists have expressed concerns about the growing problem of medicines waste, citing over-prescribing and the high volume of uncollected and unused prescriptions as key contributing factors.

Keep ReadingShow less